Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Srinivas R Viswanathan

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Elife|August 23, 2022
How splicing confers treatment resistance in prostate cancerPrathyusha Konda, Srinivas R Viswanathan
Cell|February 25, 2010
Lin28: A microRNA regulator with a macro roleSrinivas R Viswanathan, George Q Daley
Medical Oncology (Northwood, London, England)|April 22, 2010
Gallbladder lymphomaSrinivas R Viswanathan, Zain Khalpey, Stanley W Ashley
Science (New York, N.Y.)|February 23, 2008
Selective blockade of microRNA processing by Lin28Srinivas R Viswanathan, George Q Daley, Richard I Gregory
Cell Reports|August 12, 2023
Genome-guided discovery of cancer therapeutic targetsPrathyusha Konda, Simon Garinet, Eliezer M Van Allen, et al.
The Journal of Biological Chemistry|August 20, 2009
Complex N-linked glycans on Asn-89 of Kaposi sarcoma herpes virus-encoded interleukin-6 mediate optimal function by affecting cytokine protein conformationCharles S Dela Cruz, Srinivas R Viswanathan, Ayman S El-Guindy, et al.
Cell Systems|November 10, 2022
Somatic XIST activation and features of X chromosome inactivation in male human cancersAnanthan Sadagopan, Imran T Nasim, Jiao Li, et al.
Plos One|July 8, 2009
microRNA expression during trophectoderm specificationSrinivas R Viswanathan, Craig H Mermel, Jun Lu, et al.
Hematology/Oncology Clinics of North America|June 29, 2023
Novel Targeted Therapies for Renal Cell Carcinoma: Building on the Successes of Vascular Endothelial Growth Factor and mTOR InhibitionRenée Maria Saliby, Eddy Saad, Chris Labaki, et al.
Hematology/Oncology Clinics of North America|June 30, 2023
Novel Immune Therapies for Renal Cell Carcinoma: Looking Beyond the Programmed Cell Death Protein 1 and Cytotoxic T-Lymphocyte-Associated Protein 4 AxesEddy Saad, Renée Maria Saliby, Chris Labaki, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Elife|August 23, 2022
How splicing confers treatment resistance in prostate cancerPrathyusha Konda, Srinivas R Viswanathan
Cell|February 25, 2010
Lin28: A microRNA regulator with a macro roleSrinivas R Viswanathan, George Q Daley
Medical Oncology (Northwood, London, England)|April 22, 2010
Gallbladder lymphomaSrinivas R Viswanathan, Zain Khalpey, Stanley W Ashley
Science (New York, N.Y.)|February 23, 2008
Selective blockade of microRNA processing by Lin28Srinivas R Viswanathan, George Q Daley, Richard I Gregory
Cell Reports|August 12, 2023
Genome-guided discovery of cancer therapeutic targetsPrathyusha Konda, Simon Garinet, Eliezer M Van Allen, et al.
The Journal of Biological Chemistry|August 20, 2009
Complex N-linked glycans on Asn-89 of Kaposi sarcoma herpes virus-encoded interleukin-6 mediate optimal function by affecting cytokine protein conformationCharles S Dela Cruz, Srinivas R Viswanathan, Ayman S El-Guindy, et al.
Cell Systems|November 10, 2022
Somatic XIST activation and features of X chromosome inactivation in male human cancersAnanthan Sadagopan, Imran T Nasim, Jiao Li, et al.
Plos One|July 8, 2009
microRNA expression during trophectoderm specificationSrinivas R Viswanathan, Craig H Mermel, Jun Lu, et al.
Hematology/Oncology Clinics of North America|June 29, 2023
Novel Targeted Therapies for Renal Cell Carcinoma: Building on the Successes of Vascular Endothelial Growth Factor and mTOR InhibitionRenée Maria Saliby, Eddy Saad, Chris Labaki, et al.
Hematology/Oncology Clinics of North America|June 30, 2023
Novel Immune Therapies for Renal Cell Carcinoma: Looking Beyond the Programmed Cell Death Protein 1 and Cytotoxic T-Lymphocyte-Associated Protein 4 AxesEddy Saad, Renée Maria Saliby, Chris Labaki, et al.
Pageof 5